Audit 388703

FY End
2025-06-30
Total Expended
$2.37M
Findings
7
Programs
5
Year: 2025 Accepted: 2026-02-24

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1175075 2025-001 Material Weakness Yes N
1175076 2025-001 Material Weakness Yes N
1175077 2025-001 Material Weakness Yes N
1175078 2025-001 Material Weakness Yes N
1175079 2025-001 Material Weakness Yes N
1175080 2025-001 Material Weakness Yes N
1175081 2025-001 Material Weakness Yes N

Programs

ALN Program Spent Major Findings
93.788 OPIOID STR $389,426 Yes 1
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $383,077 Yes 1
14.267 CONTINUUM OF CARE PROGRAM $250,712 Yes 1
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $47,339 Yes 1
93.778 MEDICAL ASSISTANCE PROGRAM $28,660 Yes 1

Contacts

Name Title Type
PN37MFY22488 Michelle Marshall Auditee
3303153708 Allen Waddle Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of Community Drug Board, Inc. dba CHC (the "Organization") under programs of the federal government for the year ended June 30, 2025. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the "Uniform Guidance"). Because the Schedule presents only a selected portion of the operations of the Organization, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Organization.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited in reimbursement.
The Organization has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance.

Finding Details

N. Special tests and provisions Finding 2025-001 AL: 93.959 and 93.243 Program Name: Block Grants for Prevention and Treatment of Substance Abuse and Substance Abuse and Mental Health Services Projects of Regional and National Significance Criteria: 2 CFR section 200.512(a) requires the reporting package and data collection form to be submitted to the Federal Audit Clearinghouse the earlier of 30 calendar days after the reports are received from the auditors or nine months after the end of the audit period. Condition: The reporting package and data collection form were not submitted to the Federal Audit Clearinghouse within 30 days after the reports were received from the auditors. Repeat Finding from Prior Year: No Cause: Management was not aware that this requirement was in effect for this year. Effect: The reporting package and data collection form were submitted late. Recommendation: We recommend management ensure policies and procedures are in place to timely submit the reporting package and data collection form to the Federal Audit Clearinghouse. View of Responsible Officials: Management agrees with the finding and will ensure the reporting package and data collection form are submitted timely in the future.